(OKTA) Okta - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6792951054
Stock: Identity, Single Sign-On, Multi-Factor, Access Management, Lifecycle
Total Rating 37
Risk 58
Buy Signal 0.04
| Risk 5d forecast | |
|---|---|
| Volatility | 42.2% |
| Relative Tail Risk | -11.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.53 |
| Alpha | -48.63 |
| Character TTM | |
|---|---|
| Beta | 1.190 |
| Beta Downside | 0.852 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.40% |
| CAGR/Max DD | -0.02 |
EPS (Earnings per Share)
Revenue
Description: OKTA Okta March 02, 2026
Okta, Inc. (NASDAQ: OKTA) is a leading identity-as-a-service provider that helps enterprises secure and manage user, application, and device access across cloud and on-premises environments. Its platform includes Single Sign-On, Adaptive Multi-Factor Authentication, API Access Management, Universal Directory, Lifecycle Management, and a suite of zero-trust tools such as Passwordless and Attack Protection, sold directly and through channel partners worldwide.
For the most recent fiscal year, Okta reported revenue of $1.05 billion, up 20% year-over-year, and a total contract value (TCV) of $3.2 billion with net dollar retention of 115%, indicating strong expansion within its existing customer base. The identity-security market is projected to grow at a compound annual rate of roughly 14% through 2028, driven by accelerated cloud migration and enterprise adoption of zero-trust frameworks-key tailwinds for Okta’s subscription model.
For deeper insight, consider exploring Okta’s metrics on ValueRay.
Headlines to watch out for
- Subscription revenue growth drives financial performance
- Cybersecurity spending trends impact demand for identity solutions
- Competition intensifies in identity and access management market
- Data privacy regulations influence product development and compliance costs
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 235.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.53 > 1.0 |
| NWC/Revenue: 31.48% < 20% (prev 34.21%; Δ -2.73% < -1%) |
| CFO/TA 0.09 > 3% & CFO 914.0m > Net Income 235.0m |
| Net Debt (-436.0m) to EBITDA (328.0m): -1.33 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (180.4m) vs 12m ago 2.95% < -2% |
| Gross Margin: 77.36% > 18% (prev 0.76%; Δ 7.66k% > 0.5%) |
| Asset Turnover: 30.49% > 50% (prev 27.66%; Δ 2.83% > 0%) |
| Interest Coverage Ratio: 59.50 > 6 (EBITDA TTM 328.0m / Interest Expense TTM 4.00m) |
Altman Z'' -1.06
| A: 0.09 (Total Current Assets 3.47b - Total Current Liabilities 2.55b) / Total Assets 9.71b |
| B: -0.26 (Retained Earnings -2.57b / Total Assets 9.71b) |
| C: 0.02 (EBIT TTM 238.0m / Avg Total Assets 9.57b) |
| D: -0.94 (Book Value of Equity -2.55b / Total Liabilities 2.71b) |
| Altman-Z'' Score: -1.06 = CCC |
Beneish M -3.03
| DSRI: 0.99 (Receivables 687.0m/621.0m, Revenue 2.92b/2.61b) |
| GMI: 0.99 (GM 77.36% / 76.32%) |
| AQI: 1.01 (AQ_t 0.63 / AQ_t-1 0.63) |
| SGI: 1.12 (Revenue 2.92b / 2.61b) |
| TATA: -0.07 (NI 235.0m - CFO 914.0m) / TA 9.71b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of OKTA shares?
As of March 15, 2026, the stock is trading at USD 80.85 with a total of 3,108,184 shares traded.
Over the past week, the price has changed by -1.93%, over one month by -9.28%, over three months by -10.25% and over the past year by -25.76%.
Over the past week, the price has changed by -1.93%, over one month by -9.28%, over three months by -10.25% and over the past year by -25.76%.
Is OKTA a buy, sell or hold?
Okta has received a consensus analysts rating of 3.96.
Therefore, it is recommended to buy OKTA.
- StrongBuy: 18
- Buy: 8
- Hold: 18
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the OKTA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 101 | 24.9% |
| Analysts Target Price | 101 | 24.9% |
OKTA Fundamental Data Overview March 12, 2026
P/E Trailing = 60.771
P/E Forward = 20.8768
P/S = 4.8336
P/B = 2.012
P/EG = 0.8581
Revenue TTM = 2.92b USD
EBIT TTM = 238.0m USD
EBITDA TTM = 328.0m USD
Long Term Debt = 72.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 350.0m USD (from shortTermDebt, last quarter)
Debt = 422.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -436.0m USD (from netDebt column, last quarter)
Enterprise Value = 11.98b USD (14.11b + Debt 422.0m - CCE 2.55b)
Interest Coverage Ratio = 59.50 (Ebit TTM 238.0m / Interest Expense TTM 4.00m)
EV/FCF = 13.31x (Enterprise Value 11.98b / FCF TTM 900.0m)
FCF Yield = 7.51% (FCF TTM 900.0m / Enterprise Value 11.98b)
FCF Margin = 30.83% (FCF TTM 900.0m / Revenue TTM 2.92b)
Net Margin = 8.05% (Net Income TTM 235.0m / Revenue TTM 2.92b)
Gross Margin = 77.36% ((Revenue TTM 2.92b - Cost of Revenue TTM 661.0m) / Revenue TTM)
Gross Margin QoQ = 77.92% (prev 77.09%)
Tobins Q-Ratio = 1.23 (Enterprise Value 11.98b / Total Assets 9.71b)
Interest Expense / Debt = 0.24% (Interest Expense 1.00m / Debt 422.0m)
Taxrate = 10.0% (7.00m / 70.0m)
NOPAT = 214.2m (EBIT 238.0m * (1 - 10.00%))
Current Ratio = 1.36 (Total Current Assets 3.47b / Total Current Liabilities 2.55b)
Debt / Equity = 0.06 (Debt 422.0m / totalStockholderEquity, last quarter 7.00b)
Debt / EBITDA = -1.33 (Net Debt -436.0m / EBITDA 328.0m)
Debt / FCF = -0.48 (Net Debt -436.0m / FCF TTM 900.0m)
Total Stockholder Equity = 6.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.45% (Net Income 235.0m / Total Assets 9.71b)
RoE = 3.45% (Net Income TTM 235.0m / Total Stockholder Equity 6.80b)
RoCE = 3.46% (EBIT 238.0m / Capital Employed (Equity 6.80b + L.T.Debt 72.0m))
RoIC = 2.89% (NOPAT 214.2m / Invested Capital 7.41b)
WACC = 10.01% (E(14.11b)/V(14.53b) * Re(10.30%) + D(422.0m)/V(14.53b) * Rd(0.24%) * (1-Tc(0.10)))
Discount Rate = 10.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.82%
[DCF] Terminal Value 75.02% ; FCFF base≈832.0m ; Y1≈1.03b ; Y5≈1.75b
[DCF] Fair Price = 126.3 (EV 20.94b - Net Debt -436.0m = Equity 21.37b / Shares 169.2m; r=10.01% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 94.08 | EPS CAGR: 120.1% | SUE: 1.79 | # QB: 17
Revenue Correlation: 98.36 | Revenue CAGR: 17.55% | SUE: 3.80 | # QB: 17
EPS next Quarter (2026-04-30): EPS=0.85 | Chg7d=-0.019 | Chg30d=-0.020 | Revisions Net=-16 | Analysts=40
EPS current Year (2027-01-31): EPS=3.79 | Chg7d=+0.117 | Chg30d=+0.131 | Revisions Net=+29 | Growth EPS=+8.3% | Growth Revenue=+9.1%
EPS next Year (2028-01-31): EPS=4.23 | Chg7d=+0.188 | Chg30d=+0.178 | Revisions Net=+20 | Growth EPS=+11.6% | Growth Revenue=+9.4%
[Analyst] Revisions Ratio: -0.53 (7 Up / 23 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.7% (Discount Rate 10.3% - Earnings Yield 1.6%)
[Growth] Growth Spread = +0.6% (Analyst 9.3% - Implied 8.7%)
P/E Forward = 20.8768
P/S = 4.8336
P/B = 2.012
P/EG = 0.8581
Revenue TTM = 2.92b USD
EBIT TTM = 238.0m USD
EBITDA TTM = 328.0m USD
Long Term Debt = 72.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 350.0m USD (from shortTermDebt, last quarter)
Debt = 422.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -436.0m USD (from netDebt column, last quarter)
Enterprise Value = 11.98b USD (14.11b + Debt 422.0m - CCE 2.55b)
Interest Coverage Ratio = 59.50 (Ebit TTM 238.0m / Interest Expense TTM 4.00m)
EV/FCF = 13.31x (Enterprise Value 11.98b / FCF TTM 900.0m)
FCF Yield = 7.51% (FCF TTM 900.0m / Enterprise Value 11.98b)
FCF Margin = 30.83% (FCF TTM 900.0m / Revenue TTM 2.92b)
Net Margin = 8.05% (Net Income TTM 235.0m / Revenue TTM 2.92b)
Gross Margin = 77.36% ((Revenue TTM 2.92b - Cost of Revenue TTM 661.0m) / Revenue TTM)
Gross Margin QoQ = 77.92% (prev 77.09%)
Tobins Q-Ratio = 1.23 (Enterprise Value 11.98b / Total Assets 9.71b)
Interest Expense / Debt = 0.24% (Interest Expense 1.00m / Debt 422.0m)
Taxrate = 10.0% (7.00m / 70.0m)
NOPAT = 214.2m (EBIT 238.0m * (1 - 10.00%))
Current Ratio = 1.36 (Total Current Assets 3.47b / Total Current Liabilities 2.55b)
Debt / Equity = 0.06 (Debt 422.0m / totalStockholderEquity, last quarter 7.00b)
Debt / EBITDA = -1.33 (Net Debt -436.0m / EBITDA 328.0m)
Debt / FCF = -0.48 (Net Debt -436.0m / FCF TTM 900.0m)
Total Stockholder Equity = 6.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.45% (Net Income 235.0m / Total Assets 9.71b)
RoE = 3.45% (Net Income TTM 235.0m / Total Stockholder Equity 6.80b)
RoCE = 3.46% (EBIT 238.0m / Capital Employed (Equity 6.80b + L.T.Debt 72.0m))
RoIC = 2.89% (NOPAT 214.2m / Invested Capital 7.41b)
WACC = 10.01% (E(14.11b)/V(14.53b) * Re(10.30%) + D(422.0m)/V(14.53b) * Rd(0.24%) * (1-Tc(0.10)))
Discount Rate = 10.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.82%
[DCF] Terminal Value 75.02% ; FCFF base≈832.0m ; Y1≈1.03b ; Y5≈1.75b
[DCF] Fair Price = 126.3 (EV 20.94b - Net Debt -436.0m = Equity 21.37b / Shares 169.2m; r=10.01% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 94.08 | EPS CAGR: 120.1% | SUE: 1.79 | # QB: 17
Revenue Correlation: 98.36 | Revenue CAGR: 17.55% | SUE: 3.80 | # QB: 17
EPS next Quarter (2026-04-30): EPS=0.85 | Chg7d=-0.019 | Chg30d=-0.020 | Revisions Net=-16 | Analysts=40
EPS current Year (2027-01-31): EPS=3.79 | Chg7d=+0.117 | Chg30d=+0.131 | Revisions Net=+29 | Growth EPS=+8.3% | Growth Revenue=+9.1%
EPS next Year (2028-01-31): EPS=4.23 | Chg7d=+0.188 | Chg30d=+0.178 | Revisions Net=+20 | Growth EPS=+11.6% | Growth Revenue=+9.4%
[Analyst] Revisions Ratio: -0.53 (7 Up / 23 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.7% (Discount Rate 10.3% - Earnings Yield 1.6%)
[Growth] Growth Spread = +0.6% (Analyst 9.3% - Implied 8.7%)